Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors

Applied Radiation and Isotopes

Volumn 64, Issue 3, 2006, Pages 342-347

  Chen, Yue ^a   Wen Huang, Zhan ^a   He, Ling ^b   Long Zheng, Shi ^b   Lian Li, Ju ^b   Lian Qin, Da ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

99mTc DTPA DG; Radiopharmaceutical; Scintigraphic imaging; Tumor

Indexed keywords

BRAIN; CHLORIDE MINERALS; COST EFFECTIVENESS; RADIOISOTOPES; RADIOLOGY; TUMORS;

DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA); RADIOPHARMACEUTICAL; SCINTIGRAPHIC IMAGING; STANNOUS CHLORIDE REDUCTION METHOD;

TECHNETIUM COMPOUNDS;

DIETHYLENETRIAMINEPENTAACETATE DEOXYGLUCOSE TC 99M; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CANCER DIAGNOSIS; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG CLEARANCE; DRUG COST; DRUG DISTRIBUTION; DRUG IMPURITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY; NONHUMAN; PHYSICAL CHEMISTRY; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOCHEMISTRY; RAT; REDUCTION KINETICS; ROOM TEMPERATURE; SCINTIGRAPHY; TISSUE DISTRIBUTION; URINARY EXCRETION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEASIBILITY STUDIES; FEMALE; HUMANS; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; RATS; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 29144458018     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2005.08.004     Document Type: Article

References (15)

1. R. Bar-Shalom, A.Y. Valdivia, and M.D. Blaufox PET imaging in oncology Sem. Nucl. Med. 30 2002 150 185
2. 186Re(I) tricarbonyl complexes of N-(2′-Hydroxybenzyl)-2-amino- 2-deoxy- d-glucose Bioconjug. Chem. 15 2004 923 926
3. 18F]FDG-PET on the primary staging of small-cell lung cancer Eur. J. Nucl. Med. Mol. Imag. 31 2004 1614 1620
4. 18F]-2-fluoro-2-deoxy-d- glucose for PET studies of early response to anticancer treatment Nucl. Med. Biol. 26 1999 667 672
5. Y. Chen, T. Mo, A. Kuang, S. Zheng, J. Li, and C. Fan Synthesis and characterization of DTPA-metronidazole of a new technetium-containing nitroimidazole complex for imaging hypoxia J. Nucl. Med. 40 1999 313P
6. S.J. Gatley Labeled glucose analogs in the genomic era J. Nucl. Med. 44 2003 1082 1086
7. 18F-FDG PET images J. Nucl. Med. 43 2002 652 657
8. R. Kumar, P. Bhargava, M.F. Bozkurt, H. Zhuang, S. Potenta, and A. Alavi Positron emission tomography imaging in evaluation of cancer patients Indian J. Cancer 40 2003 87 100
9. J.C. Maher, N. Savaraj, W. Priebe, H. Liu, and T.J. Lampidis Differential sensitivity to 2-deoxy-d-glucose between two pancreatic cell lines correlates with GLUT-1 expression Pancreas 30 2005 e34 e39
10. T. Sasajima, T. Miyagawa, T. Oku, J.G. Gelovani, R. Finn, and R. Blasberg Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines Eur. J. Nucl. Med. Mol. Imag. 31 2004 1244 1256
11. 14C-DG autoradiography J. Nucl. Med. 45 2004 1398 1405
12. 99mTc-DTPA-mannosyl- dextran J. Nucl. Med. 42 2001 951 959
13. 99mTc labeled metronidazole, Pharm Research 16 1999 743 750
14. 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents Radiology 226 2003 465 473
15. 99mTc-ethylenedicysteine-glucosamine Cancer Biother. Radiopharm. 19 2004 443 456